Abstract: The present disclosure is directed to method of treating a herpes virus. In one embodiment, the method includes adding an effective amounts of stannous fluoride (SnF2) and antiviral synthetic nucleoside analog to a dosage form. The dosage form may be a scrim, a liquid (e.g., a nasal mist, an aerosol spray, a liquid eye drop, a liquid bandage, and the like), a mucoadhesive or a lip balm.
Type:
Application
Filed:
January 29, 2016
Publication date:
May 26, 2016
Applicant:
HERPX LLC
Inventors:
Thomas Blake, Thomas F. Parigian, David E. Walsh
Abstract: The present disclosure is directed to method of treating a herpes virus. In one embodiment, the method includes adding an effective amount of stannous fluoride (SnF2) to a dosage form. The dosage form may be a scrim, a liquid (e.g., a nasal mist, an aerosol spray, a liquid eye drop, a liquid bandage, and the like), a mucoadhesive or a lip balm.
Type:
Application
Filed:
March 7, 2013
Publication date:
September 12, 2013
Applicant:
HERPX LLC
Inventors:
Thomas Blake, Thomas S. Parigian, David E. Walsh